12.61
Finanzdaten der Arcturus Therapeutics Holdings Inc-Aktie (ARCT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
43.57%
2.959
|
2.061 | 7.196 | 17.15 | 28.30 |
| Operating Expenses |
8.03%
28.50
|
30.99 | 38.50 | 33.66 | 39.92 |
| Depreciation and Amortization |
8.81%
0.60
|
0.658 | 0.682 | 0.80 | 0.80 |
| Operating Income/Loss |
11.70%
-25.55
|
-28.93 | -31.31 | -16.51 | -11.62 |
| Income/Loss From Continuing Operations Before Tax |
-23.79
|
- | -29.08 | -13.45 | -9.176 |
| Income Tax Expense/Benefit |
-
|
- | - | - | 0.004 |
| Net Income/Loss |
11.79%
-23.79
|
-26.96 | -29.08 | -13.45 | -9.18 |
| Basic Average Shares |
0.01%
28.42
|
28.42 | 0.244 | 27.19 | 27.13 |
| Diluted Average Shares |
0.01%
28.42
|
28.42 | 0.244 | 27.19 | 27.13 |
| Basic Earnings Per Share |
11.58%
-0.84
|
-0.95 | -1.05 | -0.49 | -0.34 |
| Diluted Earnings Per Share |
11.58%
-0.84
|
-0.95 | -1.05 | -0.49 | -0.34 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):